Showing results (281-290 of 372) with videos related to

Sort By:
Pageof 38
Microvascular Research|April 21, 2006
Pericytes from human non-small cell lung carcinomas: an attractive target for anti-angiogenic therapyRebecca G Bagley, Cecile Rouleau, Sharon D Morgenbesser, et al.
Research Square|June 5, 2025
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroidsBeverly A Teicher, Thomas S Dexheimer, Thomas Silvers, et al.
Pediatric Blood & Cancer|August 28, 2021
In vivo evaluation of the lysine-specific demethylase (KDM1A/LSD1) inhibitor SP-2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC)Raushan T Kurmasheva, Stephen W Erickson, Ruolan Han, et al.
Cancer Chemotherapy and Pharmacology|September 12, 2025
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroidsBeverly A Teicher, Thomas S Dexheimer, Thomas Silvers, et al.
Cancer Research|January 15, 1987
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II)B A Teicher, S A Holden, M J Kelley, et al.
Radiation Research|May 1, 1996
Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetryH J Halpern, C Yu, M Peric, et al.
Cancer Research|September 15, 1989
Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N,N',N''-triethylenethiophosphoramideB A Teicher, D J Waxman, S A Holden, et al.
Experimental and Molecular Pathology|June 28, 2025
Polymerase Ѳ inhibitors combinations with approved and investigational agents in patient-derived tumor multi-cell type (mct) spheroidsBeverly A Teicher, Thomas S Dexheimer, Li Chen, et al.
Microvascular Research|September 2, 2008
Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularizationRebecca G Bagley, Nakayuki Honma, William Weber, et al.
Cancer Research|June 11, 2024
HTS384 NCI60: The Next Phase of the NCI60 ScreenMark W Kunkel, Nathan P Coussens, Joel Morris, et al.
Pageof 38